Results 191 to 200 of about 4,183,330 (355)

Interleukin-18 Binding Protein (IL-18BP) Deficiency Affects Lymphocyte Activation and IL-18 Expression in a Mouse Model of Liver Inflammation. [PDF]

Eur J Immunol
Devisme C, Stosskopf M, Piquet-Pellorce C, Palmer G, Gabay C, Seyec JL, Samson M, Raguenes-Nicol C.   +7 more
europepmc   +1 more source

Cell polarity regulators, multifunctional organizers of lymphocyte activation and function. [PDF]

Biomed J, 2022
Mastrogiovanni M, Di Bartolo V, Alcover A.   +2 more
europepmc   +1 more source

An activation antigen on a subpopulation of B lymphocytes identified by the monoclonal antibody CMRF-17.

, 1989
S. F. Peach, S.E. Davidson, Judith L. McKenzie, J C Nimmo, Derek N.J. Hart   +4 more
openalex   +1 more source

T Cell Glycoengineering to Modulate Immune‐Tumor Crosstalk: A Universal Non‐Genetic Strategy for Enhanced Tumor Immunotherapy

Advanced Science, EarlyView.
This study describes a T cell surface engineering strategy that integrates polymer materials with tumor immunology, aiming to achieve broad‐spectrum anti‐tumor applications of glycopolymer‐engineered T (G‐T) cells via non‐genetic modification. Glycopolymer engineering generally modulates immune‐tumor crosstalk through specific cell‐cell interactions ...
Lihua Yao, He Yang, Fangjian Shan, Xiaomeng Niu, Yichen Wang, Hengyuan Zhang, Sujian Wang, Gaojian Chen, Hong Chen   +8 more
wiley   +1 more source

Exploring the molecular landscape of lymphocyte activation gene-3: A literature review. [PDF]

Medicine (Baltimore)
Nie J, Qin X, Tao X, Huang J.
europepmc   +1 more source

Monitoring of blood immunosuppressant concentrations and lymphocyte activation for predicting viral infections following kidney transplantation: A pilot study. [PDF]

Medicine (Baltimore), 2022
Iwamoto T, Nishikawa K.
europepmc   +1 more source

Interactions of Antibody Drug Conjugate Anti‐Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy

Advanced Science, EarlyView.
Antibody drug conjugates deliver their cytotoxic anti‐tubulin or topoisomerase I inhibitor payloads to tumors through cancer cell receptor targeting. The released drug payloads induce cellular changes that interact with radiotherapy resulting in radiosensitization that improves cancer cell kill and stimulates anti‐tumor immune responses.
Jacqueline Lesperance, Bryan S. Yung, Michael M. Allevato, Marcus M Cheng, Maria F. Camargo, Robert Saddawi‐Konefka, Kanika Dhawan, Ashwyn K. Sharma, Mahsa Mortaja, Sophie Bice, Daniel J. Scanderbeg, Diego Alvarado, Jyoti Mayadev, Ramez N. Eskander, Stephen R. Adams, Pippa F. Cosper, J. Silvio Gutkind, Sunil J. Advani   +17 more
wiley   +1 more source

Lymphocyte-activation gene 3 in cancer immunotherapy: function, prognostic biomarker and therapeutic potentials. [PDF]

Front Immunol
Ren K, Hamdy H, Meyiah A, Elkord E.
europepmc   +1 more source

Impact of Multiple Sclerosis Risk Polymorphism rs7665090 on MANBA Activity, Lysosomal Endocytosis, and Lymphocyte Activation. [PDF]

Int J Mol Sci, 2022
González-Jiménez A, López-Cotarelo P, Agudo-Jiménez T, Casanova I, Silanes CL, Martín-Requero Á, Matesanz F, Urcelay E, Espino-Paisán L.   +8 more
europepmc   +1 more source

CD40 preferentially costimulates activation of CD4+ T lymphocytes. [PDF]

, 1994
Mark J. Cayabyab, Joseph H. Phillips, Lewis L. Lanier   +2 more
openalex   +1 more source